Amos Mwakigonja
- Drug Discovery top 10%
- Oncology top 10%
- Viral-associated cancers and disorders 11
- Global Cancer Incidence and Screening 3
-
- Lymphoma Diagnosis and Treatment 6
-
- Chronic Lymphocytic Leukemia Research 3
-
- Histiocytic Disorders and Treatments 6
-
- Cervical Cancer and HPV Research 3
-
- Parvovirus B19 Infection Studies 3
-
- Breast Cancer Treatment Studies 3
- Co-authors
- Ephata KaayaPeter BiberfeldFatemeh PakPawan PyakurelThomas HeidenPatrick FrancisParviz KokhaeiWilly Urassa
- Journals
- International Journal of Cancer (1 paper)European Journal of Cancer (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- TanzaniaSwedenUnited States
In The Last Decade
Amos Mwakigonja
28 papers receiving 342 citations
Peers
Comparison fields: 5 of 74
- Drug Discovery 2
- Oncology 236
- Pathology and Forensic Medicine 105
- Emergency Medical Services 19
- Genetics 28
Countries citing papers authored by Amos Mwakigonja
This map shows the geographic impact of Amos Mwakigonja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Mwakigonja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Mwakigonja more than expected).
Fields of papers citing papers by Amos Mwakigonja
This network shows the impact of papers produced by Amos Mwakigonja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Mwakigonja. The network helps show where Amos Mwakigonja may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amos Mwakigonja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 5 | |
| 10 | 2017 | 21 | |
| 11 | 2016 | 9 | |
| 12 | 2016 | 10 | |
| 13 | 2012 | 32 | |
| 14 | 2012 | 13 | |
| 15 | 2011 | 41 | |
| 16 | 2010 | 18 | |
| 17 | 2009 | 1 | |
| 18 | 2008 | 16 | |
| 19 | 2008 | 10 | |
| 20 | 2006 | 53 |
About Amos Mwakigonja
Amos Mwakigonja is a scholar working on Drug Discovery, Oncology and Pathology and Forensic Medicine, having authored 30 papers that have together received 356 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (11 papers), Histiocytic Disorders and Treatments (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Global Cancer Incidence and Screening (3 papers), Cervical Cancer and HPV Research (3 papers), Parvovirus B19 Infection Studies (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Drug Discovery (2 citations), Oncology (236 citations) and Pathology and Forensic Medicine (105 citations). Amos Mwakigonja has collaborated with scholars based in Tanzania, Sweden and United States. Frequent co-authors include Ephata Kaaya, Peter Biberfeld, Fatemeh Pak, Pawan Pyakurel, Thomas Heiden, Patrick Francis, Parviz Kokhaei, Willy Urassa, Furrat Amen and Maria Raffaella Ambrosio. Their work appears in journals such as International Journal of Cancer, European Journal of Cancer and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.